Table of Contents

company-logo

Race Oncology Limited operates as a precision oncology company in Australia. The company is developing Zantrene, a potent small molecule inhibitor of the fatso/fat mass and obesity associated protein to treat for melanoma and clear cell renal cell carcinoma, as well as acute myeloid leukaemia, breast, and ovarian cancers, which is in Phase II/III clinical trial. It has a preclinical research program with the University of Newcastle for investigating Zantrene; and strategic collaboration with the University of Wollongong to evaluate Zantrene formulations. The company was formerly known as Coronado Resources Limited and changed its name to Race Oncology Limited in July 2016. Race Oncology Limited was incorporated in 2011 and is based in Sydney, Australia.

Race Oncology Dividend Announcement

• Race Oncology does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Race Oncology dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Race Oncology Dividend History

Race Oncology Dividend Yield

Race Oncology current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Race Oncology stock? Use our calculator to estimate your expected dividend yield:

Race Oncology Financial Ratios

P/E ratio-16.63
PEG ratio-0.17
P/B ratio12.55
ROE-71.34%
Payout ratio0.00%
Current ratio9.32
Quick ratio9.32
Cash Ratio9.20

Race Oncology Dividend FAQ

Does Race Oncology stock pay dividends?
Race Oncology does not currently pay dividends to its shareholders.
Has Race Oncology ever paid a dividend?
No, Race Oncology has no a history of paying dividends to its shareholders. Race Oncology is not known for its dividend payments.
Why doesn't Race Oncology pay dividends?
There are several potential reasons why Race Oncology would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Race Oncology ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Race Oncology has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Race Oncology a dividend aristocrat?
Race Oncology is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Race Oncology a dividend king?
Race Oncology is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Race Oncology a dividend stock?
No, Race Oncology is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Race Oncology stocks?
To buy Race Oncology you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Race Oncology stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.